🌍 Clinical · subject

Clinical Medicine Syllabus

The Medicine syllabus for Clinical in full: 9 chapters, 36 topics and 169 sub-topics, every one listed below, plus 53 Medicine flashcards with answers.

9Chapters
36Topics
169Sub-topics
53Flashcards

Medicine syllabus: all 9 chapters

Expand any chapter to see its topics and sub-topics.

  1. Cardiology

    4 topics
    • Ischemic Heart Disease
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
      • Complications
    • Heart Failure
      • Types
      • Etiology
      • Clinical Features
      • Diagnosis
      • Management
    • Arrhythmias
      • Types
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Hypertension
      • Classification
      • Etiology
      • Clinical Features
      • Diagnosis
      • Management
  2. Pulmonology

    4 topics
    • Chronic Obstructive Pulmonary Disease (COPD)
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Asthma
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Pneumonia
      • Types
      • Etiology
      • Clinical Features
      • Diagnosis
      • Management
    • Pulmonary Embolism
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
  3. Gastroenterology

    4 topics
    • Peptic Ulcer Disease
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Inflammatory Bowel Disease
      • Types
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Liver Cirrhosis
      • Etiology
      • Clinical Features
      • Diagnosis
      • Complications
      • Management
    • Hepatitis
      • Types
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
  4. Neurology

    4 topics
    • Stroke
      • Types
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Epilepsy
      • Types
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Parkinson's Disease
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Multiple Sclerosis
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
  5. Nephrology

    4 topics
    • Acute Kidney Injury
      • Etiology
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Chronic Kidney Disease
      • Etiology
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Glomerulonephritis
      • Types
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Nephrotic Syndrome
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
  6. Endocrinology

    4 topics
    • Diabetes Mellitus
      • Types
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
      • Complications
    • Thyroid Disorders
      • Hyperthyroidism
      • Hypothyroidism
      • Thyroiditis
      • Thyroid Nodules
      • Diagnosis
      • Management
    • Adrenal Disorders
      • Cushing's Syndrome
      • Addison's Disease
      • Adrenal Insufficiency
      • Diagnosis
      • Management
    • Pituitary Disorders
      • Acromegaly
      • Pituitary Adenomas
      • Hypopituitarism
      • Diagnosis
      • Management
  7. Hematology

    4 topics
    • Anemia
      • Types
      • Etiology
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Leukemia
      • Types
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Lymphoma
      • Types
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Coagulation Disorders
      • Hemophilia
      • Von Willebrand Disease
      • Disseminated Intravascular Coagulation
      • Diagnosis
      • Management
  8. Rheumatology

    4 topics
    • Rheumatoid Arthritis
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Systemic Lupus Erythematosus
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Gout
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Scleroderma
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
  9. Infectious Diseases

    4 topics
    • HIV/AIDS
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
      • Complications
    • Tuberculosis
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Malaria
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management
    • Dengue Fever
      • Pathophysiology
      • Clinical Features
      • Diagnosis
      • Management

Clinical Medicine flashcards — 53 questions with answers

  1. In acute coronary syndrome, what ECG and biomarker findings distinguish STEMI from NSTEMI?

    STEMI: persistent ST-elevation (or new LBBB) with elevated troponin, indicating complete coronary occlusion and transmural injury. NSTEMI: no persistent ST-elevation (ST-depression/T-wave inversion may occur) but elevated troponin, indicating partial occlusion/subendocardial infarction. Unstable angina has similar ECG changes to NSTEMI but normal troponin.

  2. What is the initial pharmacological management ('MONA-BASH') for a suspected STEMI, and which single component most improves mortality?

    Morphine, Oxygen (only if hypoxic), Nitrates, Aspirin, plus Beta-blocker, ACE-inhibitor, Statin, Heparin/second antiplatelet. Reperfusion (primary PCI within 120 min, or thrombolysis if unavailable) is the key mortality-reducing intervention; aspirin also strongly reduces mortality.

  3. Which coronary artery territory corresponds to ST-elevation in leads II, III and aVF?

    The inferior wall of the left ventricle, usually supplied by the right coronary artery (RCA) in a right-dominant circulation.

  4. Define heart failure and distinguish HFrEF from HFpEF by ejection fraction.

    Heart failure is a clinical syndrome where the heart cannot pump blood at a rate sufficient to meet metabolic demands (or can only do so at elevated filling pressures). HFrEF (systolic): $LVEF \leq 40\%$. HFpEF (diastolic): $LVEF \geq 50\%$ with signs/symptoms of HF. HFmrEF: $LVEF$ 41–49%.

  5. What is the formula for ejection fraction, and what is the normal range?

    $$EF = \frac{SV}{EDV} \times 100\% = \frac{EDV - ESV}{EDV} \times 100\%$$ Normal $LVEF$ is approximately $55$–$70\%$.

  6. Which four drug classes form the guideline-directed 'four pillars' of HFrEF therapy that reduce mortality?

    1) ARNI (or ACE-inhibitor/ARB), 2) Beta-blocker, 3) Mineralocorticoid receptor antagonist (MRA, e.g. spironolactone), 4) SGLT2 inhibitor (e.g. dapagliflozin). Diuretics relieve congestion but do not reduce mortality.

  7. What is the natriuretic peptide (BNP/NT-proBNP) role in heart failure diagnosis?

    BNP and NT-proBNP are released by ventricular myocytes in response to wall stretch/stress. Elevated levels support a diagnosis of HF; a normal level has a high negative predictive value, effectively ruling out HF. Levels correlate with severity and prognosis.

  8. Describe the New York Heart Association (NYHA) functional classification of heart failure.

    Class I: no limitation, ordinary activity causes no symptoms. Class II: slight limitation, symptoms on ordinary activity. Class III: marked limitation, symptoms on less-than-ordinary activity. Class IV: symptoms at rest, unable to carry out any activity without discomfort.

  9. On an ECG, how do you differentiate atrial fibrillation from atrial flutter?

    Atrial fibrillation: irregularly irregular rhythm, absent P waves, chaotic fibrillatory baseline. Atrial flutter: regular 'sawtooth' flutter (F) waves (atrial rate ~300/min), typically with a fixed conduction block (e.g. 2:1 giving ventricular rate ~150/min).

  10. What are the two main management strategies for atrial fibrillation, and what score guides anticoagulation?

    Rate control (beta-blockers, non-dihydropyridine CCBs, digoxin) and rhythm control (cardioversion, antiarrhythmics, ablation). The CHA₂DS₂-VASc score estimates stroke risk to guide anticoagulation; HAS-BLED estimates bleeding risk.

  11. List the components of the CHA₂DS₂-VASc score for stroke risk in atrial fibrillation.

    Congestive HF (1), Hypertension (1), Age $\geq 75$ (2), Diabetes (1), prior Stroke/TIA/thromboembolism (2), Vascular disease (1), Age 65–74 (1), Sex category female (1). Maximum 9; anticoagulation generally recommended at $\geq 2$ (men) or $\geq 3$ (women).

  12. What is the immediate management of an unstable patient with a tachyarrhythmia and adverse features (shock, syncope, ischemia, heart failure)?

    Synchronized DC cardioversion. For unstable ventricular tachycardia with a pulse this is also synchronized cardioversion; pulseless VT/VF is treated with immediate unsynchronized defibrillation and CPR.

  13. How is blood pressure calculated from cardiac output, and how is cardiac output derived?

    $$MAP \approx CO \times SVR$$ where cardiac output $CO = HR \times SV$ (heart rate × stroke volume). Mean arterial pressure is estimated as $MAP \approx DBP + \frac{1}{3}(SBP - DBP)$.

  14. What blood pressure thresholds define hypertension by the office measurement (per common guidelines)?

    Stage 1 (ACC/AHA): $\geq 130/80$ mmHg. Stage 2: $\geq 140/90$ mmHg. ESC/NICE define hypertension as clinic BP $\geq 140/90$ mmHg, confirmed by ambulatory ($\geq 135/85$) or home readings. Normal is $< 120/80$ mmHg.

  15. Name the first-line antihypertensive drug classes and a key example of each.

    ACE inhibitors (ramipril), Angiotensin receptor blockers (losartan), Calcium channel blockers (amlodipine), and Thiazide/thiazide-like diuretics (indapamide). Beta-blockers are no longer routine first-line unless a compelling indication exists.

  16. What is the most common cause of secondary hypertension, and name three other important causes?

    Primary hyperaldosteronism (Conn's syndrome) is the most common. Others: renal parenchymal disease, renal artery stenosis, phaeochromocytoma, Cushing's syndrome, obstructive sleep apnea, and coarctation of the aorta.

  17. State the GOLD definition of COPD and the spirometry criterion for diagnosis.

    COPD is a chronic, progressive airflow limitation that is not fully reversible, caused by airway and alveolar abnormalities from noxious exposure (mainly smoking). Diagnostic spirometry: post-bronchodilator $\frac{FEV_1}{FVC} < 0.70$.

  18. How does the GOLD spirometric grading (1–4) stratify COPD severity by FEV₁?

    Based on post-bronchodilator $FEV_1$ % predicted: GOLD 1 (mild) $\geq 80\%$; GOLD 2 (moderate) $50$–$79\%$; GOLD 3 (severe) $30$–$49\%$; GOLD 4 (very severe) $< 30\%$.

  19. What is the target oxygen saturation for a COPD patient at risk of CO₂ retention, and why?

    Target $SpO_2$ 88–92%. Excessive oxygen can worsen hypercapnia via loss of hypoxic vasoconstriction (V/Q mismatch), the Haldane effect, and reduced respiratory drive, precipitating type 2 respiratory failure.

  20. Contrast asthma and COPD in terms of reversibility, typical onset age, and atopy.

    Asthma: variable/reversible airflow obstruction (bronchodilator reversibility, diurnal variation), onset often in childhood, associated with atopy/eosinophils. COPD: fixed/largely irreversible obstruction, onset usually >40 years, strongly smoking-related, neutrophilic inflammation.

Show the other 33 Medicine flashcards
  1. What defines a life-threatening acute asthma attack (key clinical/measurement features)?

    $PEF < 33\%$ predicted, $SpO_2 < 92\%$, silent chest, cyanosis, poor respiratory effort, bradycardia/arrhythmia/hypotension, exhaustion, altered consciousness, or a 'normal'/rising $PaCO_2$ (a sign of impending respiratory failure).

  2. Outline the stepwise acute management of a severe asthma attack ('OSHITME' / standard).

    Oxygen (target 94–98%), nebulized Salbutamol (SABA), Ipratropium (nebulized), Hydrocortisone/oral prednisolone (steroids), and consider IV Magnesium sulfate. Escalate to IV salbutamol/aminophylline and ICU for ventilation if refractory.

  3. What is the CURB-65 score for community-acquired pneumonia, and how is it used?

    Confusion, Urea $> 7$ mmol/L, Respiratory rate $\geq 30$, Blood pressure ($SBP < 90$ or $DBP \leq 60$), age $\geq 65$; one point each. Score 0–1: home; 2: consider admission; $\geq 3$: severe, hospital/consider ICU. Guides mortality risk and admission.

  4. What is the most common bacterial cause of community-acquired pneumonia, and which organism causes pneumonia after aspiration or in alcoholics with 'red-currant jelly' sputum?

    Streptococcus pneumoniae (pneumococcus) is the most common cause of CAP. Klebsiella pneumoniae is classically associated with aspiration/alcoholics and red-currant jelly sputum, often affecting the upper lobes.

  5. Which atypical pneumonia is associated with air-conditioning/water systems, hyponatremia, and deranged LFTs?

    Legionella pneumophila (Legionnaires' disease). Diagnosed via urinary antigen; treated with a macrolide or fluoroquinolone. Features include hyponatremia, deranged liver function, and confusion.

  6. State the modified Wells score purpose and the two possible pathways for suspected pulmonary embolism.

    The Wells score estimates the clinical probability of PE. 'PE likely' ($> 4$): proceed directly to CT pulmonary angiography. 'PE unlikely' ($\leq 4$): perform a D-dimer; if negative, PE is excluded; if positive, proceed to CTPA.

  7. What is the classic ECG finding described in pulmonary embolism (though sinus tachycardia is most common)?

    The S1Q3T3 pattern: a prominent S wave in lead I, a Q wave in lead III, and an inverted T wave in lead III, reflecting acute right heart strain. Sinus tachycardia is the most frequent ECG abnormality, and signs of RV strain may appear.

  8. What is the first-line treatment for a haemodynamically stable acute PE versus a massive PE with hypotension?

    Stable PE: anticoagulation, typically a DOAC (e.g. apixaban/rivaroxaban) or LMWH. Massive PE with haemodynamic instability (systolic BP $< 90$ mmHg): systemic thrombolysis (e.g. alteplase), or embolectomy if thrombolysis contraindicated.

  9. What is the primary cause of peptic ulcer disease, and what is the second most common cause?

    Helicobacter pylori infection is the leading cause. NSAID use (inhibiting protective prostaglandins via COX-1) is the second most common. Together they account for the vast majority of peptic ulcers; Zollinger–Ellison syndrome is a rarer cause.

  10. How do gastric and duodenal ulcer pain typically relate to eating?

    Duodenal ulcer pain is classically relieved by eating and worsens 2–5 hours later / at night (hunger pain). Gastric ulcer pain is typically worsened by eating, often leading to weight loss/food avoidance.

  11. What is the standard first-line eradication regimen for Helicobacter pylori (triple therapy)?

    A proton pump inhibitor plus two antibiotics for 7 days: typically a PPI + amoxicillin + clarithromycin (or metronidazole if penicillin-allergic). Bismuth-based quadruple therapy is used where clarithromycin resistance is high or as second-line.

  12. Compare Crohn's disease and ulcerative colitis by location, depth, and histology.

    Crohn's: any part of the GI tract (mouth to anus), 'skip lesions', transmural inflammation, non-caseating granulomas, cobblestoning, fistulae. Ulcerative colitis: continuous from the rectum, limited to colon, mucosal/submucosal only, crypt abscesses, no granulomas, pseudopolyps.

  13. Which extra-intestinal feature and smoking association distinguish Crohn's from ulcerative colitis?

    Smoking worsens Crohn's disease but is protective in ulcerative colitis. Primary sclerosing cholangitis is strongly associated with UC. Both share arthritis, erythema nodosum, uveitis; UC has a higher colorectal cancer risk with extensive long-standing disease.

  14. What are the three most common causes of liver cirrhosis worldwide?

    Chronic alcohol-related liver disease, chronic viral hepatitis (hepatitis B and C), and non-alcoholic/metabolic-associated fatty liver disease (NAFLD/MASLD). Cirrhosis is irreversible fibrosis with regenerative nodules replacing normal liver architecture.

  15. What parameters make up the Child-Pugh score for cirrhosis severity?

    Bilirubin, Albumin, Prothrombin time/INR, Ascites, and Encephalopathy ('BAP-AE'). Each scored 1–3; totals give class A (5–6), B (7–9), C (10–15), predicting mortality and surgical risk.

  16. List key complications of decompensated liver cirrhosis.

    Portal hypertension leading to oesophageal varices (variceal bleeding), ascites and spontaneous bacterial peritonitis, hepatic encephalopathy, hepatorenal syndrome, coagulopathy, and hepatocellular carcinoma.

  17. How are the routes of transmission of hepatitis A/E compared with B/C/D?

    Hepatitis A and E: faecal-oral (contaminated food/water), typically self-limiting acute infection. Hepatitis B, C, and D: blood-borne/parenteral, sexual, and vertical transmission; B and C can become chronic. Hepatitis D requires co-existing hepatitis B (uses HBsAg).

  18. Interpret hepatitis B serology: HBsAg positive, anti-HBc IgG positive, HBeAg positive.

    HBsAg positive indicates active infection (>6 months = chronic). Anti-HBc IgG indicates past/ongoing exposure (not vaccination). HBeAg positive indicates high viral replication and high infectivity. Anti-HBs alone (with negative HBsAg) indicates immunity from vaccination or cleared infection.

  19. What distinguishes an ischaemic from a haemorrhagic stroke, and why is imaging mandatory before treatment?

    Ischaemic stroke (~85%) is due to arterial occlusion (thrombus/embolus); haemorrhagic (~15%) is due to vessel rupture. A non-contrast CT head is mandatory to exclude haemorrhage before giving thrombolysis or antiplatelets, which would be dangerous in a bleed.

  20. What is the treatment time window for IV thrombolysis (alteplase) and for mechanical thrombectomy in acute ischaemic stroke?

    IV thrombolysis: within 4.5 hours of symptom onset (if no contraindications). Mechanical thrombectomy: up to 6 hours for large-vessel occlusion, extendable to 24 hours in selected patients with favourable perfusion imaging. 'Time is brain'.

  21. Give the ABCD² score components used to assess stroke risk after a TIA.

    Age $\geq 60$ (1), Blood pressure $\geq 140/90$ (1), Clinical features (unilateral weakness 2, speech disturbance without weakness 1), Duration ($\geq 60$ min 2, 10–59 min 1), Diabetes (1). Higher scores predict higher early stroke risk.

  22. Define epilepsy and distinguish focal from generalized seizures.

    Epilepsy is a tendency to recurrent, unprovoked seizures (typically $\geq 2$ seizures >24h apart, or one with high recurrence risk). Focal seizures start in one hemisphere (with/without impaired awareness). Generalized seizures involve both hemispheres from onset (e.g. tonic-clonic, absence, myoclonic).

  23. What is status epilepticus, and what is its first-line pharmacological treatment?

    Status epilepticus: a seizure lasting $\geq 5$ minutes, or recurrent seizures without recovery of consciousness between them. First-line: a benzodiazepine (IV lorazepam, or buccal midazolam/rectal diazepam); second-line IV levetiracetam, phenytoin, or valproate.

  24. Which first-line antiepileptic drugs are preferred for focal versus generalized tonic-clonic seizures, and which is teratogenic?

    Focal seizures: lamotrigine or levetiracetam first-line. Generalized tonic-clonic: sodium valproate (males) or lamotrigine/levetiracetam. Sodium valproate is highly teratogenic and avoided in women of childbearing potential. Carbamazepine can worsen absence/myoclonic seizures.

  25. What is the pathological hallmark and neurotransmitter deficit in Parkinson's disease?

    Progressive loss of dopaminergic neurons in the substantia nigra pars compacta, with intracytoplasmic Lewy bodies (α-synuclein aggregates). This causes a dopamine deficit in the nigrostriatal pathway of the basal ganglia.

  26. State the classic motor triad of Parkinson's disease and its characteristic tremor.

    Bradykinesia, rigidity ('cogwheel' / 'lead-pipe'), and a resting tremor (classically 4–6 Hz 'pill-rolling', asymmetrical, worse at rest, improved by movement). Postural instability is a fourth cardinal feature. The syndrome is typically asymmetrical at onset.

  27. What is the first-line and most effective medical treatment for Parkinson's disease, and a key long-term complication?

    Levodopa (with a peripheral dopa-decarboxylase inhibitor such as carbidopa or benserazide) is most effective for motor symptoms. Long-term use causes motor fluctuations ('wearing off', 'on-off' phenomena) and dyskinesias.

  28. Define multiple sclerosis and the concept of dissemination in time and space.

    MS is a chronic autoimmune, T-cell-mediated demyelinating disease of the CNS. Diagnosis requires demonstrating lesions disseminated in space (different CNS locations) and in time (occurring at different times), reflecting relapsing episodes of neurological dysfunction.

  29. Name two classic clinical signs of multiple sclerosis and the key CSF finding.

    Optic neuritis (painful visual loss), internuclear ophthalmoplegia, Lhermitte's sign (electric-shock sensation on neck flexion), and Uhthoff's phenomenon (symptoms worse with heat). CSF shows oligoclonal IgG bands not present in serum. MRI shows periventricular white-matter plaques.

  30. How is acute kidney injury (AKI) defined by KDIGO criteria?

    Any of: a rise in serum creatinine $\geq 26.5\,\mu mol/L$ within 48 hours; a rise in creatinine $\geq 1.5\times$ baseline within 7 days; or urine output $< 0.5\,mL/kg/h$ for $\geq 6$ hours. It is an abrupt decline in renal function.

  31. Classify the causes of AKI into pre-renal, intrinsic (renal), and post-renal with an example of each.

    Pre-renal: reduced perfusion (hypovolaemia, sepsis, heart failure). Intrinsic/renal: acute tubular necrosis, glomerulonephritis, interstitial nephritis, nephrotoxins. Post-renal: obstruction (stones, prostatic enlargement, tumour). Pre-renal is the most common cause.

  32. How is chronic kidney disease staged by eGFR, and what defines the diagnosis?

    CKD = reduced kidney function ($eGFR < 60\,mL/min/1.73m^2$) and/or markers of damage (e.g. albuminuria) for $\geq 3$ months. G1 $\geq 90$; G2 60–89; G3a 45–59; G3b 30–44; G4 15–29; G5 $< 15$ (kidney failure). Staged also by albuminuria (A1–A3).

  33. What are the emergency indications for dialysis in kidney failure (mnemonic 'AEIOU')?

    Acidosis (severe metabolic, refractory), Electrolyte disturbance (refractory hyperkalaemia), Intoxication (dialysable toxins, e.g. lithium, salicylates), Overload (refractory fluid/pulmonary oedema), Uraemia (encephalopathy, pericarditis). These represent life-threatening complications unresponsive to medical therapy.

Same Medicine syllabus in other exams

The Medicine outline above is identical in these 2 exams:

Clinical Medicine FAQ

What is in the Clinical Medicine syllabus?

Clinical Medicine is split into 9 chapters: Cardiology, Pulmonology, Gastroenterology, Neurology, Nephrology, Endocrinology, Hematology, Rheumatology and Infectious Diseases. Together they contain 36 topics and 169 sub-topics.

How many chapters are in Clinical Medicine?

9 chapters, containing 36 topics and 169 sub-topics. The largest chapter is Cardiology, with 4 topics.

Are there flashcards for Clinical Medicine?

Yes — a 53-card Medicine deck, printed in full in the flashcards section of this page and available in the Examius app with spaced repetition. The free plan covers one exam of your choice, including its flashcards; Examius Pro, a one-time purchase, unlocks every other exam and deck.